Description

3-(1-(2-(Pyrrolidin-1-Yl)Ethyl)-1H-Pyrazol-4-Yl)Benzoic Acid is a high-purity, synthetically derived organic compound featuring a benzoic acid core linked to a substituted pyrazole moiety, serving as a critical building block in advanced pharmaceutical research and development. Its molecular architecture makes it a valuable intermediate for the synthesis of novel active pharmaceutical ingredients (APIs) targeting a range of therapeutic areas. This compound is primarily utilized by research institutions and pharmaceutical companies engaged in medicinal chemistry, process development, and the discovery of new drug candidates.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the research and development of novel drug candidates, particularly in central nervous system (CNS) and oncology therapeutic areas.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Active Pharmaceutical Ingredient (API) Synthesis: Used in the multi-step synthesis of complex target molecules during process development and scale-up.
• Biochemical Tool Compound: Employed in vitro and in vivo studies to investigate specific biological pathways and protein interactions.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting pharmaceutical clients with custom synthesis and development services.

Basic Information

Product Name	3-(1-(2-(Pyrrolidin-1-Yl)Ethyl)-1H-Pyrazol-4-Yl)Benzoic Acid
CAS No.	1206970-53-7
Molecular Formula	C₁₇H₂₁N₃O₂
Molecular Weight	299.37 g/mol
Synonyms	3-[1-[2-(Pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl]benzoic acid; 3-(1-(2-(1-Pyrrolidinyl)ethyl)-1H-pyrazol-4-yl)benzoic Acid; Benzoic acid, 3-[1-[2-(1-pyrrolidinyl)ethyl]-1H-pyrazol-4-yl]-; 1206970-53-7; 3-(1-(2-(Pyrrolidin-1-yl)ethyl)-1H-pyrazol-4-yl)benzoic acid
EINECS	Contact for details

Quality Control

Our 3-(1-(2-(Pyrrolidin-1-Yl)Ethyl)-1H-Pyrazol-4-Yl)Benzoic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing purity (typically ≥95% by HPLC), identity confirmation (by IR, NMR), and impurity profiles are available for every lot. We support compliance with cGMP guidelines for advanced intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.